ODU Digital Commonsmetadata only
Metabolic Dysfunction-Associated Steatotic Liver Disease and Circadian Rhythm: Current Understanding and Implications for Future Therapeutic Interventions
circadian rhythm, glp-1 receptor agonists, hepatic encephalopathy, masld, metabolic dysfunction-associated steatotic liver disease, resmetirom, semaglutide, sleep disruption
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001613
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.